Advanced search×

The absent-minded professor: an unusual complication of melanoma.

Ragini R Kudchadkar, Rene R Gonzalez, William W Robinson, Maude M Becker, Krista K Treichel, Alan A Kimura, and Karl K Lewis

Oncology (Williston Park) 22(14):1609-14 (2008) PMID 19198219

Version: za2963e q8za6 q8zb5 q8zc7 q8zd4 q8zef q8zf8 q8zge

Similar articles you may find interesting…

  1. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-depend...
    Kevin D KD Deane, Colin I CI O'Donnell, ... V Michael VM Holers

    Arthritis Rheum 62(11):3161-72 (2010) PMID 20597112

    PURPOSE.: Pre-clinical rheumatoid arthritis (RA) biomarker elevations were evaluated and utilized to develop a model for the prediction of time to future diagnosis of seropositive RA. METHODS.: Stored samples from 73 military seropositive RA cases (and controls) from pre-RA diagnosis...
    View PDF
  2. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
    Karl D Lewis, William A Robinson, ... Rene Gonzalez

    J Clin Oncol 24(19):3157-63 (2006) PMID 16809738

    Ninety-two patients were eligible for the study. At a median follow-up of 40.4 months, relapse-free survival and overall survival are 64% and 78%, respectively. There was a lower relapse rate and improved survival for patients with a positive sentinel lymph node compared with patients with clinicall...
  3. A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors.
    Samir E SE Witta, Daniel L DL Gustafson, ... S Gail SG Eckhardt

    Clin Cancer Res 10(21):7229-37 (2004) PMID 15534096

    I combination study. This study evaluated the toxicity and pharmacokinetics of combining exisulind (150-250 mg) given orally twice daily and docetaxel (30-36 mg/m2) administered intravenously on days 1, 8, and 15 of a 4-week cycle. Twenty patients with a range of adva...